[Efficacy and tolerability of imidazole-2-hydroxybenzoate and feprazone in the treatment of some diseases of the respiratory tract].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D011298:Feprazone / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000031:analogs & derivatives*; D011897:Random Allocation; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D012459:Salicylates
D000893:Anti-Inflammatory Agents; D007093:Imidazoles; D012459:Salicylates; C043292:imidazole-2-hydroxybenzoate; D011298:Feprazone; D010653:Phenylbutazone
Efficacia e tollerabilitá dell'imidazolo-2-idrossibenzoato e del feprazone nel trattamento di alcune malattie dell'apparato respiratorio.